target,target_id,target_uniprot,target_species,ligand,ligand_id,ligand_species,ligand_pubchem_cid,smiles,inchi,inchikey,type,action,action_comment,endogenous,primary_target,concentration_range,affinity_parameter,affinity_high,affinity_median,affinity_low,original_affinity_units,original_affinity_low_nm,original_affinity_median_nm,original_affinity_high_nm,original_affinity_relation,assay_description,receptor_site,ligand_context,pubmed_id butyrylcholinesterase,2471,P06276,Human,physostigmine,6598,,5983,CNC(=O)Oc1ccc2c(c1)[C@]1(C)CCN([C@@H]1N2C)C,"InChI=1S/C15H21N3O2/c1-15-7-8-17(3)13(15)18(4)12-6-5-10(9-11(12)15)20-14(19)16-2/h5-6,9,13H,7-8H2,1-4H3,(H,16,19)/t13-,15+/m1/s1",PIJVFDBKTWXHHD-HIFRSBDPSA-N,Inhibitor,Inhibition,,,,,pIC50,7.8,,7.6,,,,,=,,,,16570913, butyrylcholinesterase,2471,P06276,Human,bambuterol,6601,,54766,O=C(N(C)C)Oc1cc(cc(c1)OC(=O)N(C)C)C(CNC(C)(C)C)O,"InChI=1S/C18H29N3O5/c1-18(2,3)19-11-15(22)12-8-13(25-16(23)20(4)5)10-14(9-12)26-17(24)21(6)7/h8-10,15,19,22H,11H2,1-7H3",ANZXOIAKUNOVQU-UHFFFAOYSA-N,Inhibitor,Inhibition,,,,,pIC50,,8.5,,,,,,=,,,,12675140, butyrylcholinesterase,2471,P06276,Human,rivastigmine,6602,,77991,CCN(C(=O)Oc1cccc(c1)[C@@H](N(C)C)C)C,"InChI=1S/C14H22N2O2/c1-6-16(5)14(17)18-13-9-7-8-12(10-13)11(2)15(3)4/h7-11H,6H2,1-5H3/t11-/m0/s1",XSVMFMHYUFZWBK-NSHDSACASA-N,Inhibitor,Inhibition,,,yes,,pIC50,,7.4,,IC50,,37.0,,=,,,,16570913, butyrylcholinesterase,2471,P06276,Human,tacrine,6687,,1935,Nc1c2CCCCc2nc2c1cccc2,"InChI=1S/C13H14N2/c14-13-9-5-1-3-7-11(9)15-12-8-4-2-6-10(12)13/h1,3,5,7H,2,4,6,8H2,(H2,14,15)",YLJREFDVOIBQDA-UHFFFAOYSA-N,Inhibitor,Inhibition,,,yes,,pKi,,7.2,,Ki,,70.0,,=,,,,18479118, butyrylcholinesterase,2471,P06276,Human,pyridostigmine,8994,,4991,C[n+]1cccc(c1)OC(=O)N(C)C,"InChI=1S/C9H13N2O2/c1-10(2)9(12)13-8-5-4-6-11(3)7-8/h4-7H,1-3H3/q+1",RVOLLAQWKVFTGE-UHFFFAOYSA-N,Inhibitor,Inhibition,,,,,pIC50,,6.05,,IC50,,900.0,,=,Inhibition of human plasma BCHE activity by a modified Ellman assay.,,,20627738,